The company is one of the most profitable in the local pharmaceutical industry, generating almost RON500 million profit in the past five years. Its profit margin stood at more than 18% last year, higher than in 2014, according to ZF calculations, while revenue amounted at almost RON539 million.
“We changed the mix of products we make. Our focus on the over-the-counter drugs is greater now, and they account for 40% compared with 25% in 2010-2011. We also concentrate on those prescription (Rx) drugs that are more profitable,” Dragos Damian, chief executive of Terapia Cluj, told ZF.
“Moreover, the clawback tax was down in the last two quarters of last year, which showed in our profits.”
Sun Pharma, the parent group of Terapia, was sixth largest local pharmaceutical business by sales in 2015, with a 4.4% market share, according to market research company Cegedim data. (EUR1=RON4.4696)
(English version by Loredana Fratila-Cristescu)